// App-Quantinova.ai

: Muscle-invasive bladder cancer: Molecular subtypes and response to neoadjuvant chemotherapy.

Researchers

Presenter

  • Roland Seiler

Principal Investigators

  • James Douglas

  • Bas W.G. van Rhijn

  • Gottfrid Sjdahl

  • Seth P. Lerner

  • Katherine A. Hoadley

  • Scott A. North

  • David James McConkey

  • Woonyoung Choi

  • William Y. Kim

  • Kim E.M van Kessel

  • George N. Thalmann

  • Elai Davicioni

  • Simon J. Crabb

  • Joost L Boormans

  • Marc Dall'Era

  • Jonathan Lawrence Wright

  • Michiel Simon Van Der Heijden

  • Peter C. Black

Medical Centers

  • Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada

  • Department of Radiology, University of Washington, Seattle, WA

  • University of Southampton, Southampten, United Kingdom

  • The Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Amsterdam, Netherlands

  • Division of Urological Research, Department of Translational Medicine, Malmo, Sweden

  • Baylor College of Medicine, Houston, TX

  • University of North Carolina, Chapel Hill, NC

  • Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC

  • Department of Pathology, Erasmus MC University Medical Center ENSAT, Rotterdam, Netherlands

  • Department of Urology, University of Bern, Bern, Switzerland

  • GenomeDx Biosciences Inc., Vancouver, BC, Canada

  • Southampton Clinical Trials Unit,University of Southampton, Southampton, United Kingdom

  • UC Davis Comprehensive Cancer Center, Sacramento, CA

  • University of Washington School of Medicine, Seattle, WA

  • Netherlands Cancer Institute (NKI), Amsterdam, Netherlands

  • The University of British Columbia, Vancouver, BC, Canada

Locations

  • Canada

  • United States

  • United Kingdom

  • Netherlands

  • Sweden

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Malondialdehyde

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A